286 related articles for article (PubMed ID: 25053392)
21. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
[TBL] [Abstract][Full Text] [Related]
22. Ivermectin in onchocerciasis control in the forest zone of Cote d'Ivoire.
Soungalo T; Soumana D; Moussa S; François R
Acta Trop; 1997 Dec; 68(3):297-300. PubMed ID: 9492914
[TBL] [Abstract][Full Text] [Related]
23. Research for control: the onchocerciasis experience.
Remme JH
Trop Med Int Health; 2004 Feb; 9(2):243-54. PubMed ID: 15040562
[TBL] [Abstract][Full Text] [Related]
24. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
Esum M; Wanji S; Tendongfor N; Enyong P
Trans R Soc Trop Med Hyg; 2001; 95(6):673-6. PubMed ID: 11816443
[TBL] [Abstract][Full Text] [Related]
25. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
Kennedy MH; Bertocchi I; Hopkins AD; Meredith SE
Ann Trop Med Parasitol; 2002 Apr; 96(3):297-307. PubMed ID: 12061976
[TBL] [Abstract][Full Text] [Related]
26. African Programme for Onchocerciasis Control: meeting of National Onchocerciasis Task Forces, September 2013.
Wkly Epidemiol Rec; 2013 Dec; 88(50):533-44. PubMed ID: 24367839
[No Abstract] [Full Text] [Related]
27. The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA).
Zouré HG; Wanji S; Noma M; Amazigo UV; Diggle PJ; Tekle AH; Remme JH
PLoS Negl Trop Dis; 2011 Jun; 5(6):e1210. PubMed ID: 21738809
[TBL] [Abstract][Full Text] [Related]
28. Validation of reports of nodules dissolution after repeated ivermectin treatment of onchocerciasis in southeastern Nigeria.
Ukaga CC; Dozie IN; Nwoke BE
East Afr Med J; 2001 Oct; 78(10):515-7. PubMed ID: 11921593
[TBL] [Abstract][Full Text] [Related]
29. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
30. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
Ndyomugyenyi R; Tukesiga E; Büttner DW; Garms R
Trop Med Int Health; 2004 Aug; 9(8):882-6. PubMed ID: 15303993
[TBL] [Abstract][Full Text] [Related]
31. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
[TBL] [Abstract][Full Text] [Related]
32. Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
Kyelem D; Medlock J; Sanou S; Bonkoungou M; Boatin B; Molyneux DH
Trop Med Int Health; 2005 Oct; 10(10):1002-4. PubMed ID: 16185234
[TBL] [Abstract][Full Text] [Related]
33. Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae.
Coffeng LE; Pion SD; O'Hanlon S; Cousens S; Abiose AO; Fischer PU; Remme JH; Dadzie KY; Murdoch ME; de Vlas SJ; Basáñez MG; Stolk WA; Boussinesq M
PLoS Negl Trop Dis; 2013; 7(4):e2168. PubMed ID: 23593528
[TBL] [Abstract][Full Text] [Related]
34. The African Programme for Onchocerciasis Control: impact on onchocercal skin disease.
Ozoh GA; Murdoch ME; Bissek AC; Hagan M; Ogbuagu K; Shamad M; Braide EI; Boussinesq M; Noma MM; Murdoch IE; Sékétéli A; Amazigo UV
Trop Med Int Health; 2011 Jul; 16(7):875-83. PubMed ID: 21481109
[TBL] [Abstract][Full Text] [Related]
35. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
[TBL] [Abstract][Full Text] [Related]
36. Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa.
O'Hanlon SJ; Slater HC; Cheke RA; Boatin BA; Coffeng LE; Pion SD; Boussinesq M; Zouré HG; Stolk WA; Basáñez MG
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004328. PubMed ID: 26771545
[TBL] [Abstract][Full Text] [Related]
37. Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challenges.
Koudou BG; Kouakou MM; Ouattara AF; Yeo S; Brika P; Meite A; Aba E; King CL; Kouakou R; Weil GJ; Fischer PU
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006897. PubMed ID: 30352058
[TBL] [Abstract][Full Text] [Related]
38. African Programme for Onchocerciasis Control: meeting of National Onchocerciasis Task Forces, September 2012.
Wkly Epidemiol Rec; 2012 Dec; 87(49/50):494-502. PubMed ID: 23311005
[No Abstract] [Full Text] [Related]
39. Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin.
Otabil KB; Gyasi SF; Awuah E; Obeng-Ofori D; Atta-Nyarko RJ; Andoh D; Conduah B; Agbenyikey L; Aseidu P; Ankrah CB; Nuhu AR; Schallig HDFH
BMC Infect Dis; 2019 May; 19(1):431. PubMed ID: 31101085
[TBL] [Abstract][Full Text] [Related]
40. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
Thomson MC; Obsomer V; Dunne M; Connor SJ; Molyneux DH
Lancet; 2000 Sep; 356(9235):1077-8. PubMed ID: 11009145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
